The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
Sign in to access this content
Sign InZealand Pharma has announced the establishment of a new research hub in Cambridge, Massachusetts, to bolster its global drug discovery capabilities. The strategic move aims to expand the company's research and development (R&D) footprint within the United States and tap into the premier biotech innovation ecosystem of the Boston area. The new facility will leverage Zealand Pharma's 25-year expertise in peptide-based medicines and metabolic health. This expansion is expected to accelerate the creation of novel therapies and enhance the company's long-term growth pipeline. By positioning itself in this key hub, the company intends to combine its specialized knowledge with the world-class talent pool available in the U.S. market. The initiative underscores Zealand Pharma's commitment to advancing its portfolio of innovative peptide treatments.